Natural Capsules Reports Q2FY27 Results With Operational EBITDA Growth Despite Losses
Natural Capsules Ltd · Press Release · 16 Nov 2026, 2:53 am
Natural Capsules Reports Q2FY27 Results With Operational EBITDA Growth Despite Losses Natural Capsules reported Q2FY27 revenue of ₹51.15 cr, up 12% YoY and 5% QoQ, driven by gelatine volume expansion and steady realisations. EBITDA surged 440% YoY and 169% QoQ to ₹3.01 cr, with margins expanding 781 bps YoY to 5.88%. Net loss narrowed to ₹(4.22) cr versus ₹(7.03) cr in Q2FY26. H1FY27 revenue reached ₹99.86 cr with EBITDA of ₹4.13 cr. The company added Mankind Pharma, cleared a Zydus Lifesciences audit, and is restructuring its API segment ahead of planned US DMF and CEP filings.
Original exchange filing (PDF)
More announcements from Natural Capsules Ltd
- The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Sunil Laxminarayana Mundra · 16 Nov 2026
- Please find enclosed herewith copy of Investor Presentation in connection with Q2 Financial Results. · 16 Nov 2026
- Pursuant to Regulation 30 and Part A of Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we would like to inform you that the Company will hold .... · 19 Nov 2026
- We wish to inform you that due to an inadvertent typographical error in the decimal placement in the Consolidated Segment- Wise Revenue, Results & Capital Employed statement we are submitting .... · 15 Nov 2026
- Approve the Allotment of Securities on Preferential Basis. · 14 Nov 2026
- In order to close the matter and maintain compliance harmony, the company has deposited the requisite fine amount as demanded by the Stock Exchanges. · 14 Nov 2026
- 1. Approved the Unaudited Consolidated & Standalone Financial Results of the Company for the Quarter and Half Yearly ended September, 2026. 2. Approved the Allotment of Securities on .... · 14 Nov 2026
- Natural Capsules Limited has informed the Exchange regarding Outcome of Board Meeting held on November 13, 2026. · 14 Nov 2026
